Greenland Mines Ltd (GRML)

• Market cap: $27.9M
• 1 day: -6.84%
• 5 days: -27.85%
• 1 month: -28.58%
• 3 months: -56.74%
• 6 months: -33.21%
• Year to date: -42.03%
• 1 year: -80.71%
• 5 years: -98.13%
• 10 years: -98.13%
• Sector: Materials
• Industry: Other Precious Metals & Mining

About: Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Employees: 5